Physician profile
Moses Kyobe
NPI 1386634384
$3,011.05
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,082 · 2020: $228 · 2021: $334 · 2023: $142 · 2024: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $896.64 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $455.65 | 2019-2024 | Camzyos |
| Amgen INC. | $309.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $250.00 | 2019-2024 | |
| Lantheus Medical Imaging, INC. | $217.81 | 2019-2021 | |
| Pfizer INC. | $155.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.91 | 2019-2020 | |
| Astellas Pharma US INC | $110.54 | 2019 | |
| Amarin Pharma, INC. | $92.37 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $72.54 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $54.33 | 2019-2020 | |
| Edwards Lifesciences Corporation | $50.09 | 2019 | |
| Lundbeck LLC | $38.58 | 2019-2020 | |
| Boston Scientific Corporation | $37.42 | 2024 | Watchman Flx |
| Abbott Laboratories | $28.41 | 2023 | Cardiomems |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.70 | 2019-2021 | |
| Infobionic, INC | $19.39 | 2020 | |
| Genzyme Corporation | $17.23 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.73 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moses Kyobe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.